Variables in predicting survival based on treating “PSA-Only” relapse
- 31 August 2003
- journal article
- review article
- Published by Elsevier in Urologic Oncology: Seminars and Original Investigations
- Vol. 21 (4), 292-304
- https://doi.org/10.1016/s1078-1439(03)00103-0
Abstract
No abstract availableKeywords
This publication has 88 references indexed in Scilit:
- Cancer Statistics, 2003CA: A Cancer Journal for Clinicians, 2003
- Is there a role for antiandrogen monotherapy in patients with metastatic prostate cancer?Prostate Cancer and Prostatic Diseases, 2001
- PREDICTING RISK OF PROSTATE SPECIFIC ANTIGEN RECURRENCE AFTER RADICAL PROSTATECTOMY WITH THE CENTER FOR PROSTATE DISEASE RESEARCH AND CANCER OF THE PROSTATE STRATEGIC UROLOGIC RESEARCH ENDEAVOR DATABASESJournal of Urology, 2001
- The Dual-Isotope ProstaScint Imaging ProcedureClinical Nuclear Medicine, 2000
- Immediate Hormonal Therapy Compared with Observation after Radical Prostatectomy and Pelvic Lymphadenectomy in Men with Node-Positive Prostate CancerNew England Journal of Medicine, 1999
- Sensitive Prostate Specific Antigen Measurements Identify Men With Long Disease-Free Intervals and Differentiate Aggressive from Indolent Cancer Recurrences within 2 Years After Radical ProstatectomyJournal of Urology, 1997
- Anti‐androgenic effects of combination finasteride plus flutamide in patients with prostatic carcinomaBritish Journal of Urology, 1996
- Estrogens in the Treatment of Prostate CancerJournal of Urology, 1995
- A Controlled Trial of Leuprolide with and without Flutamide in Prostatic CarcinomaNew England Journal of Medicine, 1989
- Combination therapy with flutamide and castration (LHRH agonist or orchiectomy) in advanced prostate cancer: A marked improvement in response and survivalJournal of Steroid Biochemistry, 1985